Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Northstar Gold Signs MOU with Hunan Nonferrous Ltd. to Develop Gold Resource (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Emblem Corp EMMBF

Healthcare Biotechnology Cannabis
"Emblem Corp is a licensed producer of medical cannabis. It is intended to cultivate and cure cannabis for medicinal use. The group operates in the business segment of production and sale of medical cannabis."


OTCPK:EMMBF - Post by User

Emblem Corp > Emblem Cash Flow - Smart Value Investing
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(36)
•••
Comment by christophwaltzon Oct 27, 2018 6:25pm
243 Views
Post# 28883004

RE:Emblem Cash Flow - Smart Value Investing

RE:Emblem Cash Flow - Smart Value InvestingThompson Reuters projects 2019 revenue between $34.1-$71.4M, and last quarterly expense she were $4M, which will of course trends up as well.

We don't know what their sale should of medical XR tabs, Capsules will be in Canada, not what the Canadian medical patient picture will look like a year from now (insurance, physician adoption, ?clinicla trials and DIN numbers). We don't know what sales of those items or the Oral Sprays will be in Germany, not their pricing. We don't even know what recreational sales will be in Canada for Symbl, nor how many other brands they will release.

How are you coming up with a projection?
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities